An Open-Label, Multicenter, Phase I, Dose Escalation Study with Phase II Expansion Cohort to Determine the Safety, Pharmacokinetics, and Preliminary Antitumor Activity of Intravenous TKM-080301 in Subjects with Advanced Hepatocellular Carcinoma

El Dika I.Lim H.Y.Yong W.P.CHIA-CHI LINYoon J.-H.Modiano M.Freilich B.Choi H.J.Chao T.-Y.Kelley R.K.Brown J.Knox J.Ryoo B.-Y.Yau T.Abou-Alfa G.K.2022-09-152022-09-1520191083-7159https://www.scopus.com/inward/record.uri?eid=2-s2.0-85059333814&doi=10.1634%2ftheoncologist.2018-0838&partnerID=40&md5=9f8d9a9472c142696e3f7535b4032688https://scholars.lib.ntu.edu.tw/handle/123456789/620256An Open-Label, Multicenter, Phase I, Dose Escalation Study with Phase II Expansion Cohort to Determine the Safety, Pharmacokinetics, and Preliminary Antitumor Activity of Intravenous TKM-080301 in Subjects with Advanced Hepatocellular Carcinomajournal article10.1634/theoncologist.2018-0838305985002-s2.0-85059333814